If you’re new to trading, then you’ve probably heard the wrong thing about options—that they’re risky, unpredictable, or difficult.

And it couldn’t be more wrong! With the Hughes Optioneering Strategy, you’ll soon learn that the safest option for new accounts is options themselves!

FATE Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 17.34%

Insider Buying (Last 12 Months): $698,138.49

Insider Selling (Last 12 Months): $4,360,813.19

Fate Therapeutics Insider Trading History Chart

Fate Therapeutics Share Price & Price History

^$5.39

▲ +0.16 (3.06%)

As of 03/24/2023 01:00 AM ET

Days: 30 | 90 | 365

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

Fate Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/13/2023	John Mendlein	Director	Buy	36,631	$5.43	$198,906.33	282,770
1/11/2023	John Mendlein	Director	Buy	88,048	$5.67	$499,232.16	246,139
1/10/2023	Bahram Valamehr	Insider	Sell	10,917	$5.24	$57,205.08	168,917
1/10/2023	Cindy Tahl	General Counsel	Sell	11,553	$5.24	$60,537.72	177,598
1/10/2023	Edward J. Dulac, III	CFO	Sell	7,331	$5.24	$38,414.44	129,470
1/10/2023	J. Scott Wolchko	CEO	Sell	45,907	$5.24	$240,552.68	385,639
8/18/2022	Edward J. Dulac, III	CFO	Sell	5,135	$29.81	$153,074.35	136,801
7/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$32.88	$986,400.00	431,546
7/7/2022	Bahram Valamehr	Insider	Sell	17,158	$30.23	$518,686.34	179,834
7/5/2022	Mark Plavsic	Insider	Sell	3,719	$24.61	$91,524.59	127,123
6/7/2022	Shefali Agarwal	Director	Sell	841	$21.89	$18,409.49	1,840
6/3/2022	John Mendlein	Director	Sell	1,364	$22.79	$31,085.56	158,091
4/21/2022	J. Scott Wolchko	CEO	Sell	30,000	$35.00	$1,050,000.00	431,546
4/19/2022	Yu-Waye Chu	Insider	Sell	4,062	$35.37	$143,672.94	151,033
4/1/2022	Cindy Tahl	General Counsel	Sell	25,000	$38.85	$971,250.00	189,151
3/10/2022	John Mendlein	Director	Sell	31,562	$35.02	$1,105,301.24
1/20/2022	J. Scott Wolchko	CEO	Sell	30,000	$40.21	$1,206,300.00
1/11/2022	Edward J. Dulac, III	CFO	Sell	1,770	$48.45	$85,756.50
1/11/2022	Yu-Waye Chu	VP	Sell	3,965	$48.51	$192,342.15
1/10/2022	Bahram Valamehr	Insider	Sell	5,596	$46.38	$259,542.48
1/10/2022	Cindy Tahl	General Counsel	Sell	7,738	$46.43	$359,275.34
1/10/2022	J. Scott Wolchko	CEO	Sell	34,156	$46.86	$1,600,550.16
12/20/2021	Edward J. Dulac, III	CFO	Sell	15,977	$60.00	$958,620.00
12/13/2021	Bahram Valamehr	Insider	Sell	25,000	$47.66	$1,191,500.00
12/10/2021	Yu-Waye Chu	VP	Sell	7,500	$51.46	$385,950.00
11/18/2021	J. Scott Wolchko	CEO	Sell	20,000	$54.27	$1,085,400.00
10/21/2021	J. Scott Wolchko	CEO	Sell	30,000	$60.22	$1,806,600.00
10/1/2021	Cindy Tahl	General Counsel	Sell	50,000	$58.83	$2,941,500.00
9/28/2021	Edward J. Dulac, III	CFO	Sell	19,460	$62.53	$1,216,833.80
8/19/2021	Edward J. Dulac, III	CFO	Sell	3,474	$88.26	$306,615.24	56,076
8/19/2021	J. Scott Wolchko	CEO	Sell	20,000	$88.01	$1,760,200.00
7/22/2021	J. Scott Wolchko	CEO	Sell	30,000	$86.05	$2,581,500.00
6/14/2021	Bahram Valamehr	Insider	Sell	25,000	$89.32	$2,233,000.00	111,896
4/23/2021	J. Scott Wolchko	CEO	Sell	30,000	$85.24	$2,557,200.00	423,793
4/16/2021	Yu-Waye Chu	VP	Sell	3,275	$83.30	$272,807.50	67,200
4/1/2021	Cindy Tahl	Insider	Sell	30,000	$83.81	$2,514,300.00	136,197
3/15/2021	Bahram Valamehr	Insider	Sell	25,000	$92.35	$2,308,750.00	120,740
1/21/2021	J. Scott Wolchko	CEO	Sell	30,000	$103.05	$3,091,500.00	393,793
1/19/2021	Cindy Tahl	General Counsel	Sell	35,000	$114.76	$4,016,600.00	125,035
1/11/2021	Cindy Tahl	General Counsel	Sell	9,483	$114.94	$1,089,976.02	96,763
1/11/2021	Daniel D Shoemaker	Insider	Sell	9,482	$114.95	$1,089,955.90	90,336
1/11/2021	J. Scott Wolchko	CEO	Sell	69,407	$116.33	$8,074,116.31	393,065
1/8/2021	Bahram Valamehr	Insider	Sell	6,230	$117.10	$729,533.00	84,455
1/8/2021	Cindy Tahl	General Counsel	Sell	6,229	$117.10	$729,415.90	96,763
1/8/2021	J. Scott Wolchko	CEO	Sell	60,820	$117.10	$7,122,022.00	393,065
1/8/2021	Redmile Group, Llc	Director	Buy	327,485	$85.50	$27,999,967.50
11/16/2020	Daniel D Shoemaker	Insider	Sell	25,000	$51.83	$1,295,750.00	113,159
11/13/2020	J. Scott Wolchko	CEO	Sell	60,000	$51.87	$3,112,200.00
10/16/2020	Cindy Tahl	General Counsel	Sell	29,199	$50.25	$1,467,249.75	128,717
6/11/2020	Redmile Group, Llc	Director	Buy	1,412,928	$28.31	$39,999,991.68

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

Institutional Buying and Selling by Quarter

Fate Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
3/10/2023	Victory Capital Management Inc.	759,802	$7.67M	0.0%	-22.5%	0.774%
2/24/2023	Natixis	2,871	$29K	0.0%	N/A	0.003%
2/17/2023	Coppell Advisory Solutions Corp.	4,190	$42K	0.0%	N/A	0.004%
2/16/2023	Alliancebernstein L.P.	301,800	$3.05M	0.0%	+196.5%	0.311%
2/16/2023	Point72 Middle East FZE	39,031	$0.39M	0.0%	N/A	0.040%
2/15/2023	CI Private Wealth LLC	30,640	$0.31M	0.0%	N/A	0.032%
2/15/2023	Capital Impact Advisors LLC	18,457	$0.19M	0.2%	-9.0%	0.019%
2/15/2023	Jane Street Group LLC	154,947	$1.56M	0.0%	+220.6%	0.159%
2/15/2023	Lazard Asset Management LLC	89,403	$0.90M	0.0%	-44.6%	0.092%
2/15/2023	Bridgefront Capital LLC	11,529	$0.12M	0.1%	N/A	0.012%
2/15/2023	Virtu Financial LLC	14,594	$0.15M	0.0%	+15.2%	0.015%
2/15/2023	State of Wisconsin Investment Board	94,606	$0.96M	0.0%	+19.9%	0.097%
2/15/2023	Schonfeld Strategic Advisors LLC	139,000	$1.40M	0.0%	+63.8%	0.143%
2/15/2023	Squarepoint Ops LLC	595,235	$6.01M	0.0%	N/A	0.613%
2/15/2023	T. Rowe Price Investment Management Inc.	433,869	$4.38M	0.0%	+6.8%	0.447%
2/15/2023	Legal & General Group Plc	119,794	$1.21M	0.0%	+11.3%	0.123%
2/15/2023	Millennium Management LLC	2,864,476	$28.90M	0.0%	+347.1%	2.948%
2/15/2023	Morgan Stanley	1,738,075	$17.54M	0.0%	+26.9%	1.789%
2/15/2023	Man Group plc	93,837	$0.95M	0.0%	+442.4%	0.097%
2/15/2023	Nomura Holdings Inc.	381,770	$3.85M	0.0%	+152.5%	0.393%
2/15/2023	Norges Bank	804,742	$8.12M	0.0%	N/A	0.828%
2/15/2023	E Fund Management Co. Ltd.	22,356	$0.23M	0.0%	+31.9%	0.023%
2/15/2023	Eagle Asset Management Inc.	376,460	$3.83M	0.0%	+2.2%	0.387%
2/15/2023	Echo Street Capital Management LLC	49,073	$0.50M	0.0%	+35.0%	0.051%
2/15/2023	Eversept Partners LP	43,562	$0.44M	0.0%	-69.2%	0.045%
2/15/2023	Avidity Partners Management LP	104,653	$1.06M	0.0%	N/A	0.108%
2/14/2023	Vident Investment Advisory LLC	55,224	$0.56M	0.0%	+58.0%	0.057%
2/14/2023	Boxer Capital LLC	1,250,000	$12.61M	0.7%	+257.1%	1.286%
2/14/2023	Price T Rowe Associates Inc. MD	2,659,058	$26.83M	0.0%	-15.4%	2.737%
2/14/2023	Verition Fund Management LLC	12,744	$0.13M	0.0%	N/A	0.013%
2/14/2023	Amundi	11,818	$68K	0.0%	-85.6%	0.012%
2/14/2023	Campbell & CO Investment Adviser LLC	49,722	$0.50M	0.1%	+244.5%	0.051%
2/14/2023	Two Sigma Investments LP	1,503,750	$15.17M	0.0%	+695.4%	1.548%
2/14/2023	Granahan Investment Management LLC	602,153	$6.08M	0.2%	+84.5%	0.620%
2/14/2023	Engineers Gate Manager LP	151,152	$1.53M	0.1%	+235.1%	0.156%
2/13/2023	Advisors Asset Management Inc.	9,970	$0.10M	0.0%	-69.6%	0.010%
2/13/2023	Charles Schwab Investment Management Inc.	614,633	$6.20M	0.0%	+2.2%	0.633%
2/13/2023	Deutsche Bank AG	233,678	$2.36M	0.0%	+4.8%	0.240%
2/13/2023	Brown Advisory Inc.	10,949	$0.11M	0.0%	-97.9%	0.011%
2/13/2023	Nikko Asset Management Americas Inc.	907,930	$9.15M	0.1%	-29.6%	0.934%
2/13/2023	Panagora Asset Management Inc.	320,320	$3.23M	0.0%	+7.4%	0.330%
2/13/2023	Wells Fargo & Company MN	50,691	$0.51M	0.0%	+8.7%	0.052%
2/13/2023	Barclays PLC	263,875	$2.66M	0.0%	+47.5%	0.272%
2/13/2023	Renaissance Technologies LLC	1,804,936	$18.21M	0.0%	+235.8%	1.858%
2/13/2023	Seven Eight Capital LP	213,733	$2.16M	0.6%	+936.8%	0.220%
2/13/2023	ExodusPoint Capital Management LP	245,758	$2.48M	0.0%	+864.7%	0.253%
2/13/2023	Credit Suisse AG	1,013,305	$10.22M	0.0%	-0.2%	1.043%
2/13/2023	Geode Capital Management LLC	1,564,291	$15.78M	0.0%	+4.3%	1.610%
2/13/2023	American Century Companies Inc.	327,880	$3.31M	0.0%	+38.4%	0.337%
2/13/2023	GSA Capital Partners LLP	58,432	$0.59M	0.1%	N/A	0.060%
2/13/2023	Atria Wealth Solutions Inc.	11,064	$0.11M	0.0%	N/A	0.011%
2/13/2023	Capital Fund Management S.A.	109,546	$1.11M	0.0%	N/A	0.113%
2/13/2023	JPMorgan Chase & Co.	1,467,004	$14.80M	0.0%	-27.8%	1.510%
2/13/2023	Teacher Retirement System of Texas	23,583	$0.24M	0.0%	-6.8%	0.024%
2/10/2023	Bank of America Corp DE	477,877	$4.82M	0.0%	+42.7%	0.492%
2/10/2023	Schroder Investment Management Group	137,341	$1.39M	0.0%	+3.6%	0.141%
2/10/2023	AXQ Capital LP	68,139	$0.69M	0.5%	N/A	0.070%
2/10/2023	Connor Clark & Lunn Investment Management Ltd.	380,862	$3.84M	0.0%	+27.0%	0.392%
2/10/2023	Victory Capital Management Inc.	759,802	$7.67M	0.0%	-22.5%	0.782%
2/10/2023	HRT Financial LP	37,915	$0.38M	0.0%	-64.3%	0.039%
2/10/2023	Advisor Group Holdings Inc.	6,371	$63K	0.0%	+520.4%	0.007%
2/10/2023	CI Investments Inc.	3,082	$31K	0.0%	+413.7%	0.003%
2/9/2023	Mirae Asset Global Investments Co. Ltd.	66,823	$0.67M	0.0%	+14.8%	0.069%
2/9/2023	Victory Capital Management Inc.	759,802	$7.62M	0.0%	-22.5%	0.782%
2/9/2023	Dimensional Fund Advisors LP	551,469	$5.56M	0.0%	+130.1%	0.568%
2/9/2023	Cowen AND Company LLC	15,000	$0.15M	0.0%	N/A	0.015%
2/9/2023	Citigroup Inc.	195,693	$1.98M	0.0%	-14.5%	0.201%
2/9/2023	HighTower Advisors LLC	15,775	$0.16M	0.0%	-9.7%	0.016%
2/8/2023	Raymond James & Associates	24,745	$0.25M	0.0%	-8.3%	0.025%
2/8/2023	UBS Group AG	291,911	$2.95M	0.0%	+12,243.0%	0.300%
2/8/2023	Skandinaviska Enskilda Banken AB publ	309,359	$3.12M	0.0%	-0.6%	0.318%
2/8/2023	California Public Employees Retirement System	158,802	$1.60M	0.0%	-9.9%	0.163%
2/8/2023	Swiss National Bank	187,400	$1.89M	0.0%	+2.2%	0.193%
2/8/2023	Parametrica Management Ltd	32,254	$0.33M	0.7%	+127.7%	0.033%
2/7/2023	State Board of Administration of Florida Retirement System	27,876	$0.28M	0.0%	-12.1%	0.029%
2/7/2023	Fox Run Management L.L.C.	18,551	$0.19M	0.1%	N/A	0.019%
2/7/2023	TD Asset Management Inc	70,826	$0.72M	0.0%	-20.9%	0.073%
2/7/2023	WCM Investment Management LLC	185,273	$1.87M	0.0%	-1.3%	0.191%
2/7/2023	Mitsubishi UFJ Kokusai Asset Management Co. Ltd.	12,649	$0.13M	0.0%	+14.4%	0.013%
2/6/2023	Los Angeles Capital Management LLC	17,313	$0.18M	0.0%	-8.0%	0.018%
2/2/2023	Mach 1 Financial Group LLC	51,574	$0.52M	0.2%	N/A	0.053%
2/2/2023	AtonRa Partners	14,912	$0.15M	0.2%	-21.3%	0.015%
2/1/2023	State of New Jersey Common Pension Fund D	118,540	$1.20M	0.0%	+49.6%	0.122%
2/1/2023	Zurcher Kantonalbank Zurich Cantonalbank	14,660	$0.15M	0.0%	+47.0%	0.015%
2/1/2023	International Biotechnology Trust PLC	46,000	$0.46M	0.1%	-62.0%	0.047%
1/31/2023	AE Wealth Management LLC	51,331	$0.52M	0.0%	N/A	0.053%
1/31/2023	Monaco Asset Management SAM	250,000	$2.52M	0.7%	N/A	0.257%
1/30/2023	New York State Common Retirement Fund	70,928	$0.72M	0.0%	-5.9%	0.073%
1/30/2023	Sumitomo Mitsui Trust Holdings Inc.	907,930	$9.16M	0.0%	-29.6%	0.934%
1/27/2023	Alpha DNA Investment Management LLC	102,094	$1.03M	0.4%	N/A	0.105%
1/27/2023	Rice Hall James & Associates LLC	212,864	$2.15M	0.1%	-2.9%	0.219%
1/26/2023	Comerica Bank	133,760	$0.77M	0.0%	+8.4%	0.138%
1/24/2023	ARK Investment Management LLC	4,214,863	$42.53M	0.4%	-63.8%	4.338%
1/23/2023	Allspring Global Investments Holdings LLC	40,060	$0.40M	0.0%	-83.9%	0.041%
1/18/2023	Exchange Traded Concepts LLC	41,297	$0.42M	0.0%	+32.7%	0.042%
12/8/2022	Bank of New York Mellon Corp	390,269	$8.75M	0.0%	+11.3%	0.402%
11/22/2022	Capital Impact Advisors LLC	20,273	$0.41M	0.4%	+22.7%	0.021%
11/21/2022	California State Teachers Retirement System	99,341	$2.23M	0.0%	-1.8%	0.102%
11/16/2022	Glenmede Trust Co. NA	9,245	$0.21M	0.0%	N/A	0.010%
11/16/2022	Alpha Paradigm Partners LLC	56,644	$1.27M	0.6%	+28.3%	0.058%

Data available starting January 2016

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. The company was founded by Philip Beachy, Sheng Ding, Rudolf Jaenisch, Randall T. Moon, Michael Rudnicki, David Scadden, Leonard Zon, Alexander Rives, Scott Wolchko, and John D. Mendlein on April 27, 2007 and is headquartered in San Diego, CA.

Today's Range

Now: $5.39

$5.05

$5.43

50 Day Range

MA: $5.89

$4.88

$6.87

52 Week Range

Now: $5.39

$4.02

$43.12

Volume

1,708,987 shs

Average Volume

3,514,024 shs

Market Capitalization

$529.08 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.53

Who are the company insiders with the largest holdings of Fate Therapeutics?: Fate Therapeutics' top insider investors include:
J Scott Wolchko (CEO)
John Mendlein (Director)
Cindy Tahl (General Counsel)
Bahram Valamehr (Insider)
Yu-Waye Chu (Insider)
Edward J Dulac III (CFO)
Cindy Tahl (Insider)
Mark Plavsic (Insider)
Yu-Waye Chu (VP)
Shefali Agarwal (Director)
Louis T Petrillo (Insider)
Learn More about top insider investors at Fate Therapeutics.
Who are the major institutional investors of Fate Therapeutics?: Fate Therapeutics' top institutional investors include:
ARK Investment Management LLC — 4.34%
Millennium Management LLC — 2.95%
Price T Rowe Associates Inc. MD — 2.74%
Renaissance Technologies LLC — 1.86%
Morgan Stanley — 1.79%
Geode Capital Management LLC — 1.61%
Learn More about top institutional investors of Fate Therapeutics stock.
Which institutional investors are selling Fate Therapeutics stock?: Within the previous quarter, FATE stock was sold by these institutional investors:
ARK Investment Management LLC
JPMorgan Chase & Co.
Brown Advisory Inc.
Price T Rowe Associates Inc. MD
Sumitomo Mitsui Trust Holdings Inc.
Nikko Asset Management Americas Inc.
Victory Capital Management Inc.
Victory Capital Management Inc.
In the last year, company insiders that have sold Fate Therapeutics company stock include:
J Scott Wolchko (CEO)
John Mendlein (Director)
Cindy Tahl (General Counsel)
Bahram Valamehr (Insider)
Yu-Waye Chu (Insider)
Edward J Dulac III (CFO)
Cindy Tahl (Insider)
Mark Plavsic (Insider)
Learn More investors selling Fate Therapeutics stock.
Which institutional investors are buying Fate Therapeutics stock?: During the previous quarter, FATE stock was acquired by institutional investors including:
Millennium Management LLC
Two Sigma Investments LP
Renaissance Technologies LLC
Boxer Capital LLC
Norges Bank
Squarepoint Ops LLC
Morgan Stanley
Dimensional Fund Advisors LP

The Safest Option in Trades!

From Tradewins | Ad

Click here now!

FATE Insider Trading

Fate Therapeutics Insider Trading History Chart

Fate Therapeutics Share Price & Price History

Fate Therapeutics Insider Trading History

SEC Filings (Institutional Ownership Changes) for Fate Therapeutics (NASDAQ:FATE)

Institutional Buying and Selling by Quarter

Fate Therapeutics Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Fate Therapeutics?

Who are the major institutional investors of Fate Therapeutics?

Which institutional investors are selling Fate Therapeutics stock?

Which institutional investors are buying Fate Therapeutics stock?